Literature DB >> 24277218

Proton magnetic resonance studies of the decomposition of 4-hydroxycyclophosphamide, a microsomal metabolite of cyclophosphamide.

E J Valente1, K K Chan, K L Servis.   

Abstract

The proposed tautomeric equilibrium between the microsomal metabolite of cyclophosphamide, 4-hydroxycyclophosphamide, and the open chain aldophosphamide, and the subsequent facile β-elimination to generate acrolein and phosphoramide mustard have been confirmed by proton magnetic resonance studies. When 4-hydroxycyclophosphamide, initially maintained in CDC13 at -20°C, was allowed to equilibrate at 15°C, a singlet at 9.76 δ and a triplet at 2.88 δ appeared concomitantly which were assigned to the aldehydic proton and the protons α to the carbonyl of aldophosphamide, respectively. Further reaction led to the appearance of several NMR signals that indicated the irreversible formation of acrolein (multiplet at 9.55 δ) and phosphoramide mustard. Polymerization occurred approximately 2 hours after the initiation of the reaction. The kinetic data of the reaction sequence are discussed.

Entities:  

Year:  1984        PMID: 24277218     DOI: 10.1023/A:1016307515811

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  Studies on cyclophosphamide metabolites and their related compounds. 2. Preparation of an active species of cyclophosphamide and related compounds.

Authors:  A Takamizawa; S Matsumoto; T Iwata; Y Tochino; K Katagiri; K Yamaguchi
Journal:  J Med Chem       Date:  1975-04       Impact factor: 7.446

2.  Studies on the mechanism of action of cytoxan. Evidence of activation in vivo and in vitro.

Authors:  G E FOLEY; O M FRIEDMAN; B P DROLET
Journal:  Cancer Res       Date:  1961-01       Impact factor: 12.701

3.  Identification of aldophosphamide as a metabolite of cyclophosphamide in vitro and in vivo in humans.

Authors:  C Fenselau; M N Kan; S S Rao; A Myles; O M Friedman; M Colvin
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

4.  Isolation and identification of a stabilized derivative of aldophosphamide, a major metabolite of cyclophosphamide.

Authors:  R F Struck
Journal:  Cancer Res       Date:  1974-11       Impact factor: 12.701

5.  Studies on cyclophosphamide metabolites and their related compounds. I.

Authors:  A Takamizawa; Y Tochino; Y Hamashima; T Iwata
Journal:  Chem Pharm Bull (Tokyo)       Date:  1972-08       Impact factor: 1.645

6.  Evidence for an aldehyde possessing alkylating activity as the primary metabolite of cyclophosphamide.

Authors:  N E Sladek
Journal:  Cancer Res       Date:  1973-04       Impact factor: 12.701

7.  Alkylating properties of phosphoramide mustard.

Authors:  M Colvin; R B Brundrett; M N Kan; I Jardine; C Fenselau
Journal:  Cancer Res       Date:  1976-03       Impact factor: 12.701

8.  The problem of oncostatic specificity of cyclophosphamide (NSC-26271): Studies on reactions that control the alkylating and cytotoxic activity.

Authors:  H J Hohorst; U Draeger; G Peter; G Voelcker
Journal:  Cancer Treat Rep       Date:  1976-04

9.  Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.

Authors:  O M Friedman; I Wodinsky; A Myles
Journal:  Cancer Treat Rep       Date:  1976-04

10.  Aldophosphamide: synthesis, characterization, and comparison with "Hohorst's aldophosphamide".

Authors:  R F Struck
Journal:  Cancer Treat Rep       Date:  1976-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.